Overview

Update
IPO / Stock
Went Public on May 30, 2013 / NASDAQ:EPZM
Total Equity Funding
$51.5M in 4 Rounds from 8 Investors
Headquarters:
Cambridge, MA
Description:
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.
Founders:
,
Categories:
Biopharma, Health Care, Biotechnology
Website:
http://www.epizyme.com
Social:

Company Details

Update
Founded:
2007
Contact:
16173490707
Employees:
51 - 100 | 6 in Crunchbase

Epizyme is a biopharmaceutical company located in Cambridge, MA, that is focused on researching treatments for blood cancer and tumors.

Founded in late 2007, the company has brought together premier academic and industry leaders to rapidly translate the exciting discoveries emerging from epigenetic research into specific programs that will produce important, novel, molecularly targeted drugs of the future.

Funding Rounds (5) - $61.5M

Update
DateAmount / RoundValuationLead InvestorInvestors
Feb, 2014$10M / Post Ipo Equity1
Oct, 2011$4M / Venture1
Jun, 2011$7.5M / Venture1
Dec, 2009$8M / Series B1
Oct, 2009$32M / Series B5

Current Team (6)

Update

Offices/Locations (1)

Update
  • Office

    Cambridge, MA

    USA

Past Team (4)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos